The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

General Notices

• Notice of Change to PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
  (NOT-CA-22-105)
  National Cancer Institute

• Notice on Informational Webinar on the "Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01)" Program
  (NOT-GM-22-036)
  National Institute of General Medical Sciences

• Notice of Applicant Information Webinar for the NIGMS Bridges to the Baccalaureate (B2B)(T34) and the Bridges to the Doctorate (B2D)(T32)
  (NOT-GM-22-040)
  National Institute of General Medical Sciences

• Notice of Special Interest (NOSI): Advancing Research on Early Pregnancy Loss
  (NOT-HD-22-026)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health

• Notice of Availability of Frequently Asked Questions (FAQs) for RFA-HL-23-015 and RFA-HL-23-016 "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI) (UG3/UH3) (U24)"
  (NOT-HL-22-027)
  National Heart, Lung, and Blood Institute

• Notice of NHLBI Participation in PAR-22-132 "Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low-and Middle-Income Countries and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)"
  (NOT-HL-22-035)
  National Heart, Lung, and Blood Institute

• NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications
  (NOT-HL-22-036)
  National Heart, Lung, and Blood Institute

• Notice of Information: High Priority Countries for the Center for Global Mental Health Research
  (NOT-MH-22-235)
  National Institute of Mental Health

• Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24)
  (NOT-MH-22-245)
  National Institute of Mental Health

• Notice of Participation of Additional NIH Institutes and Centers in RFA-HG-22-002: Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
  (NOT-OD-22-156)
  Office of the Director, NIH
  National Institute on Minority Health and Health Disparities
  Office of the Director, NIH

• Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029
  (NOT-AR-22-023)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases

• Request for Information: Improving our understanding of the role of diet and other factors in the Developmental Origins of Health and Disease (DOHaD)
  (NOT-OD-22-157)
  Office of Naval Research

Notice of Changes to Funding Opportunities

• Notice of Correction for NOT-CA-22-014 "Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment"
  (NOT-CA-22-102)
  National Cancer Institute

• Notice to update Application Due Dates for PAR -18-604 "Vet-LIRN Network Capacity-Building Projects (U18)"
  (NOT-FD-22-014)
  Food and Drug Administration

• FDA Notice of Special Interest (NOSI) to update NOT-FD-22-006 with new application due dates for COVID-19 Capacity Building Grants for PAR-18-604 Vet-LIRN Network Capacity-Building Projects (U18)
  (NOT-FD-22-016)
  Food and Drug Administration

• Notice of Change to Application Due Date for RFA-RM-22-016 "Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)"
  (NOT-RM-22-018)
  Office of Strategic Coordination (Common Fund)

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
  (NOT-CA-22-112)
  National Cancer Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRIs Diversity Action Plan (R25 Clinical Trials Not Allowed)
  (NOT-HG-22-023)
  National Human Genome Research Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed)
  (NOT-MH-22-265)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke

• Notice of Intent to Publish a Funding Opportunity Announcement for Environmental influences on Child Health Outcomes (ECHO) Measurement Core (U24) Clinical Trial Not Allowed
  (NOT-OD-22-169)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed
  (NOT-OD-22-170)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)
  (NOT-OD-22-171)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Environmental influences on Child Health Outcomes (ECHO) Cohort Coordinating Center (U2C) (Clinical Trial Not Allowed)
  (NOT-OD-22-172)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24) Clinical Trial Not Allowed
  (NOT-OD-22-173)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)
  (NOT-OD-22-174)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3)
  (NOT-OD-22-175)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Institute of Mental Health

Notices of Special Interest

• Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease
  (NOT-AG-22-025)
  National Institute on Aging
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

• Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01)
  (NOT-HL-22-030)
  National Heart, Lung, and Blood Institute

• Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes
  (NOT-OD-22-167)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health

Funding Opportunities

• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-22-169)
  National Institute of Mental Health
   
• Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
  (PAR-22-170)
  National Institute of Mental Health
   
• CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
  (PAR-22-209)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
   
• Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed)
  (PAR-22-211)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
   
• Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
  (PAR-22-213)
  National Institute on Aging
   
• Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
  (RFA-AG-23-017)
  National Institute on Aging
   
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
  (RFA-AG-23-029)
  National Institute on Aging
   
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
  (RFA-AG-23-030)
  National Institute on Aging
   
• HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Optional)
  (RFA-DA-23-045)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 02, 2023
• HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)
  (RFA-DA-23-046)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
   
• New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
  (RFA-HL-23-015)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
   
• New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-HL-23-016)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
   
• Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  (RFA-HL-23-017)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
   
• Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
  (RFA-HL-23-019)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
   
• Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
  (RFA-HL-23-020)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
   
• Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)
  (RFA-NS-23-014)
  National Institute of Neurological Disorders and Stroke
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)  or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).